Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Sep;83(3):679-87.
doi: 10.1016/j.exer.2006.03.009. Epub 2006 May 8.

Regulation of cysteine cathepsin expression by oxidative stress in the retinal pigment epithelium/choroid of the mouse

Affiliations

Regulation of cysteine cathepsin expression by oxidative stress in the retinal pigment epithelium/choroid of the mouse

Parvaneh Alizadeh et al. Exp Eye Res. 2006 Sep.

Abstract

Cystatin C is the major inhibitor of the cysteine cathepsins. Polymorphisms in the cystatin C gene have recently been associated with the risk of developing Age-related Macular Degeneration (AMD). Oxidative stress is also thought to play a key role in the pathogenesis of AMD. We surveyed the retinal pigment epithelium (RPE) and choroid of the C57BL/6J mouse for the expression of the cysteine cathepsins under normoxic and hyperoxic (75% O(2)) conditions. Microarray analysis of RPE/choroid mRNA revealed the expression of cathepsins B and L, as well as cystatin C under all experimental conditions. The microarray results were confirmed by real-time quantitative polymerase chain reaction (PCR). Localization of the mRNA species for cystatin C and cathepsin B, as well as, localization of protein species for cystatin C, cathepsins B and L were performed to evaluate the tissue distribution of these species. Our results indicate that cystatin C is largely synthesized in the RPE and secreted from the basal side. Cathepsin B is the major cysteine protease in the RPE and choroid. The expression of all mRNAs and proteins was elevated by exposure to oxidative stress.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Affymetrix GeneChip Expression Analysis of cathepsins B, L, S and cystatin C, in the RPE/choroid of C57BL/6J mice after 14 days of exposure to hyperoxic (75% oxygen) or normoxic conditions (21% oxygen). Gene expression of cathepsins B, L, S and cystatin C increased under oxidative stress (solid columns). Asterisks denotes a statistically significant difference between the normoxic and hyperoxic group (p<0.05).
Fig. 2
Fig. 2
Cathepsin B, cathepsin L and cystatin C mRNA, measured using real-time quantitative TaqMan PCR on the RPE/choroid of C57BL/6J-Tyrc-2J/J mice, after 14 days of exposure to hyperoxic or normoxic conditions. Each value represents an average of three measurements from three eyes. Cathepsin B, L and cystatin C mRNA levels were significantly elevated under oxidative stress (solid columns). Asterisks denotes a statistically significant difference between the normoxic and hyperoxic groups (p<0.005).
Fig. 3
Fig. 3
Cathepsin B mRNA expression in the RPE/choroid of the C57BL/6J-Tyrc-2J/J mouse, after 14 days of exposure to hyperoxic or normoxic conditions (control). (A) Staining of normoxic tissue with the sense riboprobe. (B) Staining of normoxic tissue with the anti-sense riboprobe. (C) Staining of hyperoxic tissue with the sense riboprobe. (D) Staining of hyperoxic tissue with the anti-sense riboprobe. Scale bar = 10 μM.
Fig. 4
Fig. 4
Cystatin C mRNA expression in the RPE/choroid of the C57BL/6J-Tyrc-2J/J mouse, after 14 days of exposure to hyperoxic or normoxic conditions (control). (A) Staining of normoxic tissue with the sense riboprobe. (B) Staining of normoxic tissue with the anti-sense riboprobe. (C) Staining of hyperoxic tissue with the sense riboprobe. (D) Staining of hyperoxic tissue with the anti-sense riboprobe. Scale bar = 10 μM.
Fig. 5
Fig. 5
Cathepsin B immunoreactivity in the RPE/choroid of the C57BL/6J-Tyrc-2J/J mouse, after 14 days of exposure to hyperoxic or normoxic conditions (control). (A) Staining of normoxic tissue with normal IgG. (B) Staining of normoxic tissue with anti-cathepsin B antibody. (C) Staining of hyperoxic tissue with normal IgG. (D) Staining of hyperoxic tissue with anti-cathepsin B antibody. Scale bar = 10 μM.
Fig. 6
Fig. 6
Cathepsin L immunoreactivity in the RPE/choroid of the C57BL/6J-Tyrc-2J/J mouse, after 14 days of exposure to hyperoxic or normoxic conditions (control). (A) Staining of normoxic tissue with normal IgG. (B) Staining of normoxic tissue with anti-cathepsin L antibody. (C) Staining of hyperoxic tissue with normal IgG. (D) Staining of hyperoxic tissue with anti-cathepsin L antibody. Scale bar = 10 μM.
Fig. 7
Fig. 7
Cystatin C immunoreactivity in the RPE/choroid of the C57BL/6J-Tyrc-2J/J mouse, after 14 days of exposure to hyperoxic or normoxic conditions (control). (A) Staining of normoxic tissue with normal IgG. (B) Staining of normoxic tissue with anti-cystatin C antibody. (C) Staining of hyperoxic tissue with normal IgG. Scale bar = 10 μM.

References

    1. ARED. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119:1417–1436. - PMC - PubMed
    1. Barka T, van der Noen H. Expression of the cysteine proteinase inhibitor cystatin C mRNA in rat eye. Anat Rec. 1994;239:343–348. - PubMed
    1. Bernstein HG, Reichenbach A, Kirschke H, Wiederanders B. Cell type-specific distribution of cathepsin B and D immunoreactivity within the rabbit retina. Neurosci Lett. 1989;98:135–138. - PubMed
    1. Bhutto IA, Kim SY, McLeod DS, Merges C, Fukai N, Olsen BR, Lutty GA. Localization of collagen XVIII and the endostatin portion of collagen XVIII in aged human control eyes and eyes with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2004;45:1544–1552. - PubMed
    1. Braissant O, Wahli W. Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development. Endocrinology. 1998;139:2748–2754. - PubMed

Publication types